022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Mergers & Acquisitions | 29 October 2012

Mahindra Lifespaces Buys Land From Nycomed Pharma

by Sushil Surana
Mahindra Lifespaces Buys Land From Nycomed Pharma
Share on Social Media Email Facebook Twitter Linkedin
 
@Hemant_Kaul

Mahindra Group led Mahindra Lifespaces has purchased 12,000 sq m plot from Nycomed Pharma Private limited for around R205 Cr, according to TOI.

The plot located at Andheri, currently houses a bungalow, two guest houses, a R&D facility and an electric sub-station.

The plot has a development potential of 5 lakh sq ft under the new building planning rules framed by the civic body. Mahindra is planning to set up a high-end residential complex on the plot.

Nycomed Pharma was Nycomed A/S (Switzerland) 100% subsidiary in India. Established in 2003, the company constitutes Nycomed's only global R&D centre outside of Europe.

In 2011, Japanese pharma major – Takeda Global acquired Nycomed A/S for 9.6 Bn euros.

Incorporated in 1999 as Gesco Corporation, Mahindra Lifespaces has two major business segments – residential development and integrated business cities. The company is executing two integrated business city projects in Chennai and Jaipur through its subsidiaries – Mahindra World City Developers Limited and, respectively. M&M held 51% stake in MLDL as on March 31, 2012.

BIBA Apparels Acquires Stake In Manish Arora's INDIAN Brand

BIBA Apparels Acquires Stake In Manish Arora's INDIAN Brand

BIBA Apparels Private Limited, a Future Venture company has formed 51:49 JV with fashion designer Manish Arora to promote Manish Arora's premium ethnic wear brand - 'INDIAN by Manish Arora'.

Read More...

FIPB green-signals Sharekhan proposal to sell 100 per cent stake to BNP Paribas

FIPB green-signals Sharekhan proposal to sell 100 per cent stake to BNP Paribas

The Foreign Investment Promotion Board (FIPB) green-signals broking firm Sharekhan Ltd.’s proposal to sell 100 per cent stake to BNP Paribas after many deferrals. This move will allow the former to entice foreign investment of worth Rs 2,060 crore. Currently, this procedure falls under FDI policy that means, a foreign investor can have up to 100 percent stake in a stockbroking firm only under the automatic route.

Read More...
Subscribe
Enter your Email address
to receive all the news